What is NDC 67979-511?

67979-511 is the product NDC for Aveed (testosterone undecanoate), Testosterone undecanoate 250 mg/mL injection, listed with the FDA by Endo USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Aveed (Testosterone undecanoate).

Endo USA, Inc., NDC labeler code 67979. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Aveed?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Aveed NDC 67979-511 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67979-511Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67979-0511Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67979-511-43	6797905114367979051143	1 VIAL, SINGLE-USE in 1 CARTON (67979-511-43) / 3 mL in 1 VIAL, SINGLE-USEMarketed from Mar 5, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aveed
Generic name (nonproprietary): testosterone undecanoate
Active ingredients: Testosterone undecanoate — 250 mg/mL
Dosage form: Injection
Route: Intramuscular
Labeler: Endo USA, Inc.NDC labeler code 67979
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022219
Marketing start: Mar 5, 2014
Listing expires: Dec 31, 2027
DEA schedule: CIII
Other FDA classes: Androgen Receptor Agonists (Mechanism)Androstanes (Chemical structure)
Identifiers: Product ID 67979-511_da249940-81ef-4af3-8c59-4697e0404e71SPL ID da249940-81ef-4af3-8c59-4697e0404e71SPL set ID f80f025b-17d8-40af-8739-20ce07902045RxCUI 1490661, 1490667UNII H16A5VCT9C
Pharmacologic class: Androgen

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N467979051143 followed by a unit qualifier and the quantity

Package 67979-0511-43. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 15, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

AVEED is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. Primary hypogonadism (congenital or acquired): testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituita…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 67979-511

What is NDC 67979-511?: 67979-511 is the product NDC for Aveed (testosterone undecanoate), Testosterone undecanoate 250 mg/mL injection, listed with the FDA by Endo USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Aveed (Testosterone undecanoate).
What is the active ingredient?: Testosterone undecanoate.
Who is the labeler?: Endo USA, Inc., NDC labeler code 67979. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Aveed?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Aveed (Testosterone undecanoate) NDC 67979-511